Sustaining Generic Medicines Markets in Europe. [On- line]. Available from: http://www.egagenerics.com/ doc/simoens-report_2006-04.pdf [Accessed: 22nd Nov2011].
Gaither CA, Kirking DM, Ascione FJ, Welage LS. Con- sumers’ views on generic medications. J Am Pharm As- soc 2001; 41:729-36.
Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Jansen RD, Kochen MM, et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther 2005; 43:472-9.
Horne R. Patients’ beliefs about treatment: the hidden determinant of treatment outcome? J Am Pharm Assoc 2001:41:729-9.
Leventhal H, Benyamini Y, Brownlee S, Diefenbach M, Leventhal AE, Patrick – Miller L, Robitaille C. Illness representations: theoretical foundations. In: Percep- tion of health&illness. Editors: Petrie KJ, Weinman JA, Harwood Academic Publishers. Nederlands: 1997. P.19- 45(ISBN 90-5702-103-X).
Gross Domestic Product at Market Prices. [Online]. Available from: http://epp.eurostat.ec.europa.eu/tgm/ refreshTableAction.do?tab=table&plugin=1&init=1&pc ode=tec00001&language=en [Accessed: 22nd Nov2011].
The Role of Generic Medicines in Europe. European Ge- neric Medicines Association. [Online]. Available from: http://www.egagenerics.com/gen-geneurope.htm [Ac- cessed: 27th Nov2011].
IMS 2009. Data on file. [Corporate access].
Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J AM Pharm Assoc 2000; 40:378-83.
Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther 2003; 25:2875-90.
Tilyard MW, Dovey SM, Rosenstreich D. General practi- tioners’ views on generic medication and substitution. N Z Med J 1990; 103:318-20.
Year 2012,
Volume: 16 Issue: 1, 36 - 40, 07.03.2014
Sustaining Generic Medicines Markets in Europe. [On- line]. Available from: http://www.egagenerics.com/ doc/simoens-report_2006-04.pdf [Accessed: 22nd Nov2011].
Gaither CA, Kirking DM, Ascione FJ, Welage LS. Con- sumers’ views on generic medications. J Am Pharm As- soc 2001; 41:729-36.
Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Jansen RD, Kochen MM, et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther 2005; 43:472-9.
Horne R. Patients’ beliefs about treatment: the hidden determinant of treatment outcome? J Am Pharm Assoc 2001:41:729-9.
Leventhal H, Benyamini Y, Brownlee S, Diefenbach M, Leventhal AE, Patrick – Miller L, Robitaille C. Illness representations: theoretical foundations. In: Percep- tion of health&illness. Editors: Petrie KJ, Weinman JA, Harwood Academic Publishers. Nederlands: 1997. P.19- 45(ISBN 90-5702-103-X).
Gross Domestic Product at Market Prices. [Online]. Available from: http://epp.eurostat.ec.europa.eu/tgm/ refreshTableAction.do?tab=table&plugin=1&init=1&pc ode=tec00001&language=en [Accessed: 22nd Nov2011].
The Role of Generic Medicines in Europe. European Ge- neric Medicines Association. [Online]. Available from: http://www.egagenerics.com/gen-geneurope.htm [Ac- cessed: 27th Nov2011].
IMS 2009. Data on file. [Corporate access].
Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J AM Pharm Assoc 2000; 40:378-83.
Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther 2003; 25:2875-90.
Tilyard MW, Dovey SM, Rosenstreich D. General practi- tioners’ views on generic medication and substitution. N Z Med J 1990; 103:318-20.
Lebanova, H., Manolov, D., & Getov, I. (2014). Patients’ attitude about generics – Bulgarian perspective. Marmara Pharmaceutical Journal, 16(1), 36-40. https://doi.org/10.12991/mpj.79357
AMA
Lebanova H, Manolov D, Getov I. Patients’ attitude about generics – Bulgarian perspective. J Res Pharm. March 2014;16(1):36-40. doi:10.12991/mpj.79357
Chicago
Lebanova, Hristina, Dimitar Manolov, and Ilko Getov. “Patients’ Attitude about Generics – Bulgarian Perspective”. Marmara Pharmaceutical Journal 16, no. 1 (March 2014): 36-40. https://doi.org/10.12991/mpj.79357.
EndNote
Lebanova H, Manolov D, Getov I (March 1, 2014) Patients’ attitude about generics – Bulgarian perspective. Marmara Pharmaceutical Journal 16 1 36–40.
IEEE
H. Lebanova, D. Manolov, and I. Getov, “Patients’ attitude about generics – Bulgarian perspective”, J Res Pharm, vol. 16, no. 1, pp. 36–40, 2014, doi: 10.12991/mpj.79357.
ISNAD
Lebanova, Hristina et al. “Patients’ Attitude about Generics – Bulgarian Perspective”. Marmara Pharmaceutical Journal 16/1 (March 2014), 36-40. https://doi.org/10.12991/mpj.79357.
JAMA
Lebanova H, Manolov D, Getov I. Patients’ attitude about generics – Bulgarian perspective. J Res Pharm. 2014;16:36–40.
MLA
Lebanova, Hristina et al. “Patients’ Attitude about Generics – Bulgarian Perspective”. Marmara Pharmaceutical Journal, vol. 16, no. 1, 2014, pp. 36-40, doi:10.12991/mpj.79357.
Vancouver
Lebanova H, Manolov D, Getov I. Patients’ attitude about generics – Bulgarian perspective. J Res Pharm. 2014;16(1):36-40.